{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-006727","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2025-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.450922+00:00","generated_at":"2026-05-17T07:52:46.956739+00:00","sec_items":["1.01","2.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PharmaCyte Biotech invests $3M in TNF Pharma for convertible preferred and warrants linked to LightSolver license","bullets":["PharmaCyte purchased $3M of TNF Series H convertible preferred shares (convertible at $5) and warrants for 600,000 common shares at $5 exercise price.","Investment supports TNF's license with LightSolver for a light-speed computing platform for cryptocurrency mining and blockchain.","TNF plans to change its name and ticker to reflect the new strategy; warrants expire 5 years after stockholder approval.","Preferred shares carry 7% annual dividend (15% on trigger events) and price-based anti-dilution adjustments.","PharmaCyte reports total assets over $55M as of April 30, 2025, and will use cash for this investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-006727","json":"https://secwatch.observer/filing/0001683168-25-006727.json","markdown":"https://secwatch.observer/filing/0001683168-25-006727.md","text":"https://secwatch.observer/filing/0001683168-25-006727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/0001683168-25-006727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825006727/pharmacyte_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:52:46.956739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}